FAS −1,377 G/A polymorphism is associated with cancer susceptibility: evidence from 10,564 cases and 12,075 controls
- 19 February 2009
- journal article
- research article
- Published by Springer Nature in Human Genetics
- Vol. 125 (4) , 431-435
Abstract
Published data on the association between FAS −1,377 G/A polymorphism and cancer risk are inconclusive. To derive a more precise estimation of the relationship, a meta-analysis was performed. A total of 17 studies including 10,564 cases and 12,075 controls were involved in this meta-analysis. Overall, significantly elevated cancer risk was associated with AA variant genotype when all the eligible studies were pooled into the meta-analysis (for AA vs GG: OR = 1.19; 95% CI = 1.01–1.40; P heterogeneity = 0.05; for recessive model: OR = 1.21; 95% CI = 1.04–1.41; P heterogeneity = 0.05). In the subgroup analysis by ethnicity, borderline statistically significantly increased risks were found among Asians for recessive model (OR = 1.20; 95% CI = 1.00–1.45; P heterogeneity = 0.01). In the subgroup analysis by population-based controls or hospital-based controls, statistically significantly increased risks were found among groups with population-based controls for AA versus GG (OR = 1.27; 95% CI = 1.02–1.58; P heterogeneity = 0.05) and recessive model (OR = 1.25; 95% CI = 1.00–1.59; P heterogeneity = 0.01). For breast cancer, borderline statistically significantly increased risks were found for AA versus GG (OR = 1.29; 95% CI = 1.00–1.67; P heterogeneity = 0.41). In summary, this meta-analysis suggests that the FAS −1,377 G/A polymorphism is associated with cancer susceptibility.Keywords
This publication has 23 references indexed in Scilit:
- Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancerCarcinogenesis, 2008
- Exploratory Analysis of Fas Gene Polymorphisms in Pediatric Osteosarcoma PatientsJournal of Pediatric Hematology/Oncology, 2007
- Polymorphisms in the FAS and FASL genes and risk of lung cancer in a Korean populationLung Cancer, 2006
- Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancerCarcinogenesis, 2006
- Polymorphisms of FAS and FAS Ligand Genes Involved in the Death Pathway and Risk and Progression of Squamous Cell Carcinoma of the Head and NeckClinical Cancer Research, 2006
- Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case–control analysisPharmacogenetics and Genomics, 2006
- Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: An analysis of haplotype and gene–gene interactionGynecologic Oncology, 2005
- FASL –844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancerJournal of Experimental Medicine, 2005
- Re: Polymorphisms of Death Pathway Genes FAS and FASL in Esophageal Squamous-Cell CarcinomaJNCI: Journal of the National Cancer Institute, 2004
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986